Navigation Links
Exposure to Pesticides May Raise the Risk of Parkinson’s Disease in Me

According to a new study, men who are exposed to pesticides that is used for killing bugs or weeds are at the high risk of developing Parkinson’s disease //.

Parkinson's disease is a disorder of the brain that affects the control of muscles and so may affect movement, speech and posture.

Mayo Clinic researchers Roberta Frigerio and others studied 149 patients who developed Parkinson's disease between 1976 and 1995.

Men who use pesticides to kill bugs or weeds - either at work or at home - may have doubled the risk of getting Parkinson's disease, the researchers said in a study in the June issue of the journal Movement Disorders.

However, women exposed to pesticides do not face such risk, reported the online edition of health magazine WebMD.

"There is something biologically different between men and women when exposed to pesticides," a researcher said.

"The risk was 2.4-fold more than a doubling of the risk in unexposed men," the researcher said.

But when the researchers looked only at men with occupational exposures such as farmers, they did not find a link to Parkinson's disease.

But when they included men exposed to pesticides via hobbies such as gardening, the link became apparent.

(Source: IANS News)
'"/>




Page: 1

Related medicine news :

1. Exposure to EMF may cause leukemia
2. Exposure To Tobacco Smoke Can Lead To Sickle Cell Crisis
3. Radiation Exposure Found To Affect Intellect Later In Life
4. Cancer Risk From Exposure To Diagnostic X-Rays
5. Limiting Infants Exposure To Smoke At Home
6. Exposure To Night Light may Increase The Risk Of Leukemia
7. Understanding The Harmful Effects Of Radiation Exposure
8. Asbestos Exposure Associated With An Increased Risk For Autoimmune Disease
9. Low dose Radiation Exposure May Cause Cancer
10. Exposure to cigarette smoke when in the womb can lead to asthma
11. Exposure to Pesticides in Schools Produces Illnesses Among Employees, Students
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... Yardley, PA (PRWEB) , ... March 23, 2017 ... ... received Patient Oriented Disease Management Accreditation from the NCQA. The accreditation covers StayWell’s ... programs. , Accredited status is granted to organizations that have excellent programs ...
(Date:3/23/2017)... ... , ... The TouchPoint Solution, home of Buzzies *, is boosting the ... , “Buzzies change the way we interact with stress and live our day-to-day lives,” ... date in December 2016, The TouchPoint Solution has sold more than $750,000 in product ...
(Date:3/23/2017)... , ... March 23, 2017 , ... After raising more ... FaceCradle , the most-funded travel pillow in crowdfunding history, has established a ... its wildly popular travel innovation to Americans. , “We’re excited to be operating on ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... today announced rapid completion of the strategic executive team expansion needed to further ... to the ChenMed executive team,” says Christopher Chen, MD, ChenMed Chief Executive Officer. ...
(Date:3/23/2017)... ... March 23, 2017 , ... Natural Subsistence, ... aspects of people’s health and nutrition, announced its product Leyzene is now available ... Subsistence develops nutritional supplements that help people improve all aspects of their health ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... MUMBAI , March 23, 2017 ... de Piramal Enterprises Limited, anuncia el nombramiento de ... PPS ofrece una plataforma de servicios integrados completa ... Needleman desempeñará un cargo clave en el crecimiento ... comercial, Needleman será responsable de impulsar todas las ...
(Date:3/23/2017)... 23, 2017  Galmed Pharmaceuticals Ltd. (Nasdaq: ... clinical-stage biopharmaceutical company focused on the development of ... nonalcoholic steatohepatitis, or NASH, and other liver diseases, ... twelve months ended December 31, 2016, and announced new ... demonstrating Aramchol™,s potential direct effect on liver fibrosis. ...
(Date:3/23/2017)... 23, 2017 ReNeuron reported in December ... in chronic stroke patients, despite not meeting the three-month time ... the Action Research Arm Test (ARAT). As a result, the ... controlled clinical study in 2017. Beyond CTX, we expect safety ... 2017 and Phase I data from its critical limb ischaemia ...
Breaking Medicine Technology: